Skip to content

Change in AP at other companies

TFX
TeleflexTFX
$8.2M+147%
Johnson & Johnson logo
Johnson & JohnsonJNJ
-$3.92B-84.4%
Haemonetics logo
HaemoneticsHAE
-$6.7M
CONMED logo
CONMEDCNMD
$10.48M+243%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$4.49M+0.9%
Edwards Lifesciences logo
Edwards LifesciencesEW
-$347.1M-236%

Other financials

Income statement

See full
Revenue$5.2B+11.6%
Gross profit$3.6B+12.6%
Operating income$1.1B+19.5%
Net income$1.3B+99.3%
EPS (diluted)$0.90+100%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total debt$659.0M-94.1%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.3%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$63.44B-56.6%
P/E17.8×-40.8×
P/S3.1×-4.8×

Profitability

See full
Gross margin69.2%+0.5pp
Operating margin18.4%+2.2pp
Net margin17.3%+5.7pp
FCF margin16.9%-0.3pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Scientific's change in AP?
Boston Scientific (BSX) reported change in AP of -$512M in Q1 2026.
How has Boston Scientific's change in AP changed year-over-year?
Boston Scientific's change in AP decreased by 33.0% year-over-year, from -$385M to -$512M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.